DEXTROMETHORPHAN O-DEMETHYLATION IN LIVER-MICROSOMES AS A PROTOTYPE REACTION TO MONITOR CYTOCHROME-P-450 DB1 ACTIVITY

被引：129

作者：

DAYER, P

LEEMANN, T

STRIBERNI, R

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 01期

关键词：

D O I：

10.1038/clpt.1989.6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：34 / 40

页数：7

共 31 条

[21]

OMURA T, 1964, J BIOL CHEM, V239, P2370

[22] EVIDENCE FOR ALTERED CATALYTIC PROPERTIES OF THE CYTOCHROME-P-450 INVOLVED IN SPARTEINE OXIDATION IN POOR METABOLIZERS [J].

OSIKOWSKAEVERS, B ;

DAYER, P ;

MEYER, UA ;

ROBERTZ, GM ;

EICHELBAUM, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (03) :320-325

[23] COMPETITIVE-INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY BETA-ADRENOCEPTOR ANTAGONISTS AND OTHER CARDIOVASCULAR DRUGS [J].

OTTON, SV ;

INABA, T ;

KALOW, W .

LIFE SCIENCES, 1984, 34 (01) :73-80

[24] MONOGENIC CONTROL OF VARIATIONS IN ANTIPYRINE METABOLITE FORMATION - NEW POLYMORPHISM OF HEPATIC DRUG OXIDATION [J].

PENNO, MB ;

VESELL, ES .

JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06) :1698-1709

[25]

PRICEEVANS DA, 1980, J MED GENET, V17, P102

[26] POLYMORPHIC DEXTROMETHORPHAN METABOLISM - CO-SEGREGATION OF OXIDATIVE O-DEMETHYLATION WITH DEBRISOQUIN HYDROXYLATION [J].

SCHMID, B ;

BIRCHER, J ;

PREISIG, R ;

KUPFER, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) :618-624

[27] PHARMACOGENETICS OF TOLBUTAMIDE METABOLISM IN HUMANS [J].

SCOTT, J ;

POFFENBARGER, PL .

DIABETES, 1979, 28 (01) :41-51

[28]

SHEINER LB, 1983, ELSFIT PROGRAM EXTEN

[29]

Snedecor G.W., 1980, STAT METHODS, V7th, P507

[30]

SYVALAHTI EKG, 1986, BRIT J CLIN PHARMACO, V22, P89

← 1 2 3 4 →